Literature DB >> 25022261

Germ-line and somatic DICER1 mutations in pineoblastoma.

Leanne de Kock1, Nelly Sabbaghian, Harriet Druker, Evan Weber, Nancy Hamel, Suzanne Miller, Catherine S Choong, Nicholas G Gottardo, Ursula R Kees, Surya P Rednam, Liselotte P van Hest, Marjolijn C Jongmans, Shalini Jhangiani, James R Lupski, Margaret Zacharin, Dorothée Bouron-Dal Soglio, Annie Huang, John R Priest, Arie Perry, Sabine Mueller, Steffen Albrecht, David Malkin, Richard G Grundy, William D Foulkes.   

Abstract

Germ-line RB-1 mutations predispose to pineoblastoma (PinB), but other predisposing genetic factors are not well established. We recently identified a germ-line DICER1 mutation in a child with a PinB. This was accompanied by loss of heterozygosity (LOH) of the wild-type allele within the tumour. We set out to establish the prevalence of DICER1 mutations in an opportunistically ascertained series of PinBs. Twenty-one PinB cases were studied: Eighteen cases had not undergone previous testing for DICER1 mutations; three patients were known carriers of germ-line DICER1 mutations. The eighteen PinBs were sequenced by Sanger and/or Fluidigm-based next-generation sequencing to identify DICER1 mutations in blood gDNA and/or tumour gDNA. Testing for somatic DICER1 mutations was also conducted on one case with a known germ-line DICER1 mutation. From the eighteen PinBs, we identified four deleterious DICER1 mutations, three of which were germ line in origin, and one for which a germ line versus somatic origin could not be determined; in all four, the second allele was also inactivated leading to complete loss of DICER1 protein. No somatic DICER1 RNase IIIb mutations were identified. One PinB arising in a germ-line DICER1 mutation carrier was found to have LOH. This study suggests that germ-line DICER1 mutations make a clinically significant contribution to PinB, establishing DICER1 as an important susceptibility gene for PinB and demonstrates PinB to be a manifestation of a germ-line DICER1 mutation. The means by which the second allele is inactivated may differ from other DICER1-related tumours.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25022261      PMCID: PMC4381868          DOI: 10.1007/s00401-014-1318-7

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  49 in total

1.  Germ-line and somatic DICER1 mutations in a pleuropulmonary blastoma.

Authors:  Leanne de Kock; François Plourde; Melissa T Carter; Nancy Hamel; Archana Srivastava; M Stephen Meyn; Jocelyne Arseneau; Dorothée Bouron-Dal Soglio; William D Foulkes
Journal:  Pediatr Blood Cancer       Date:  2013-07-19       Impact factor: 3.167

2.  Medulloepithelioma in DICER1 syndrome treated with resection.

Authors:  A Ramasubramanian; Z M Correa; J J Augsburger; R A Sisk; D A Plager
Journal:  Eye (Lond)       Date:  2013-05-03       Impact factor: 3.775

3.  Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function.

Authors:  Ender Karaca; Stefan Weitzer; Davut Pehlivan; Hiroshi Shiraishi; Tasos Gogakos; Toshikatsu Hanada; Shalini N Jhangiani; Wojciech Wiszniewski; Marjorie Withers; Ian M Campbell; Serkan Erdin; Sedat Isikay; Luis M Franco; Claudia Gonzaga-Jauregui; Tomasz Gambin; Violet Gelowani; Jill V Hunter; Gozde Yesil; Erkan Koparir; Sarenur Yilmaz; Miguel Brown; Daniel Briskin; Markus Hafner; Pavel Morozov; Thalia A Farazi; Christian Bernreuther; Markus Glatzel; Siegfried Trattnig; Joachim Friske; Claudia Kronnerwetter; Matthew N Bainbridge; Alper Gezdirici; Mehmet Seven; Donna M Muzny; Eric Boerwinkle; Mustafa Ozen; Tim Clausen; Thomas Tuschl; Adnan Yuksel; Andreas Hess; Richard A Gibbs; Javier Martinez; Josef M Penninger; James R Lupski
Journal:  Cell       Date:  2014-04-24       Impact factor: 41.582

4.  DICER1 mutations in an adolescent with cervical embryonal rhabdomyosarcoma (cERMS).

Authors:  Eva Tomiak; Leanne de Kock; David Grynspan; Raveena Ramphal; William D Foulkes
Journal:  Pediatr Blood Cancer       Date:  2013-10-22       Impact factor: 3.167

5.  Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.

Authors:  Diane E Rushlow; Berber M Mol; Jennifer Y Kennett; Stephanie Yee; Sanja Pajovic; Brigitte L Thériault; Nadia L Prigoda-Lee; Clarellen Spencer; Helen Dimaras; Timothy W Corson; Renée Pang; Christine Massey; Roseline Godbout; Zhe Jiang; Eldad Zacksenhaus; Katherine Paton; Annette C Moll; Claude Houdayer; Anthony Raizis; William Halliday; Wan L Lam; Paul C Boutros; Dietmar Lohmann; Josephine C Dorsman; Brenda L Gallie
Journal:  Lancet Oncol       Date:  2013-03-13       Impact factor: 41.316

6.  Incidence of pineal gland cyst and pineoblastoma in children with retinoblastoma during the chemoreduction era.

Authors:  Aparna Ramasubramanian; Christina Kytasty; Anna T Meadows; Jerry A Shields; Ann Leahey; Carol L Shields
Journal:  Am J Ophthalmol       Date:  2013-07-20       Impact factor: 5.258

7.  Germ-line deletion in DICER1 revealed by a novel MLPA assay using synthetic oligonucleotides.

Authors:  Nelly Sabbaghian; Archana Srivastava; Nancy Hamel; François Plourde; Malgorzata Gajtko-Metera; Marek Niedziela; William D Foulkes
Journal:  Eur J Hum Genet       Date:  2013-09-25       Impact factor: 4.246

8.  Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences.

Authors:  T J Pugh; W Yu; J Yang; A L Field; L Ambrogio; S L Carter; K Cibulskis; P Giannikopoulos; A Kiezun; J Kim; A McKenna; E Nickerson; G Getz; S Hoffher; Y H Messinger; L P Dehner; C W M Roberts; C Rodriguez-Galindo; G M Williams; C T Rossi; M Meyerson; D A Hill
Journal:  Oncogene       Date:  2014-06-09       Impact factor: 9.867

9.  Loss of functional Dicer in mouse radial glia cell-autonomously prolongs cortical neurogenesis.

Authors:  Tomasz Jan Nowakowski; Karolina Sandra Mysiak; Timothy O'Leary; Vassiliki Fotaki; Thomas Pratt; David Jonathan Price
Journal:  Dev Biol       Date:  2013-09-05       Impact factor: 3.582

10.  DICER1 hotspot mutations in non-epithelial gonadal tumours.

Authors:  L Witkowski; J Mattina; S Schönberger; M J Murray; C S Choong; D G Huntsman; J S Reis-Filho; W G McCluggage; J C Nicholson; N Coleman; G Calaminus; D T Schneider; J Arseneau; C J R Stewart; W D Foulkes
Journal:  Br J Cancer       Date:  2013-10-17       Impact factor: 7.640

View more
  46 in total

1.  Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.

Authors:  Elke Pfaff; Christian Aichmüller; Martin Sill; Damian Stichel; Matija Snuderl; Matthias A Karajannis; Martin U Schuhmann; Jens Schittenhelm; Martin Hasselblatt; Christian Thomas; Andrey Korshunov; Marina Rhizova; Andrea Wittmann; Anna Kaufhold; Murat Iskar; Petra Ketteler; Dietmar Lohmann; Brent A Orr; David W Ellison; Katja von Hoff; Martin Mynarek; Stefan Rutkowski; Felix Sahm; Andreas von Deimling; Peter Lichter; Marcel Kool; Marc Zapatka; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2019-11-25       Impact factor: 17.088

Review 2.  Retinoblastoma, the visible CNS tumor: A review.

Authors:  Helen Dimaras; Timothy W Corson
Journal:  J Neurosci Res       Date:  2018-01-03       Impact factor: 4.164

Review 3.  [Hereditary tumor syndromes in neuropathology].

Authors:  C Mawrin
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

4.  Expanding the spectrum of dicer1-associated sarcomas.

Authors:  Mikako Warren; Matthew C Hiemenz; Ryan Schmidt; Jared Shows; Jennifer Cotter; Stephanie Toll; David M Parham; Jaclyn A Biegel; Leo Mascarenhas; Rachana Shah
Journal:  Mod Pathol       Date:  2019-09-19       Impact factor: 7.842

5.  Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in DICER1 syndrome: a unique variant of the two-hit tumor suppression model.

Authors:  Mark Brenneman; Amanda Field; Jiandong Yang; Gretchen Williams; Leslie Doros; Christopher Rossi; Kris Ann Schultz; Avi Rosenberg; Jennifer Ivanovich; Joyce Turner; Heather Gordish-Dressman; Douglas Stewart; Weiying Yu; Anne Harris; Peter Schoettler; Paul Goodfellow; Louis Dehner; Yoav Messinger; D Ashley Hill
Journal:  F1000Res       Date:  2015-07-10

6.  Biallelic Dicer1 Loss Mediated by aP2-Cre Drives Angiosarcoma.

Authors:  Jason A Hanna; Catherine J Drummond; Matthew R Garcia; Jonathan C Go; David Finkelstein; Jerold E Rehg; Mark E Hatley
Journal:  Cancer Res       Date:  2017-09-15       Impact factor: 12.701

7.  Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.

Authors:  Mona K Wu; Gordan M Vujanic; Somayyeh Fahiminiya; Noriko Watanabe; Paul S Thorner; Maureen J O'Sullivan; Marc R Fabian; William D Foulkes
Journal:  Mod Pathol       Date:  2017-09-01       Impact factor: 7.842

8.  Ovarian tumors related to intronic mutations in DICER1: a report from the international ovarian and testicular stromal tumor registry.

Authors:  Kris Ann P Schultz; Anne Harris; Yoav Messinger; Susan Sencer; Shari Baldinger; Louis P Dehner; D Ashley Hill
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

Review 9.  Pineal Gland Tumor Microenvironment.

Authors:  Joham Choque-Velasquez; Szymon Baluszek; Roberto Colasanti; Sajjad Muhammad; Juha Hernesniemi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 10.  Management of familial cancer: sequencing, surveillance and society.

Authors:  Nardin Samuel; Anita Villani; Conrad V Fernandez; David Malkin
Journal:  Nat Rev Clin Oncol       Date:  2014-10-14       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.